We are live on ! Find out more
BIOSU

BioPlus Acquisition Corp. Unit
BIOSU

Delisted

BIOSU was delisted on the 6th of October, 2023.

Back to rankings

15 hedge funds and large institutions have $23.7M invested in BioPlus Acquisition Corp. Unit in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% less capital invested

Capital invested by funds: $33.6M → $23.7M (-$9.92M)

38% less funds holding

Funds holding: 24 → 15 (-9)

90% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 10

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
15
Holders Change
-9
Holders Change %
-37.5%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CSS
Cubist Systematic Strategies
Connecticut
+$342K

Top Sellers

Rank Fund Capital Flow
1
ACM
Atalaya Capital Management
New York
-$2.52M
2
MF
Magnetar Financial
Illinois
-$2M
3
SFM
Spartan Fund Management
Canada
-$1.48M
4
FLC
Fifth Lane Capital
Texas
-$1.03M
5
WC
Wealthspring Capital
New York
-$576K

BIOSU Hedge Fund Activity: Q3 2022 in Review

15 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Unit (BIOSU) for Q3 2022, worth a combined $23.7M — down 29% from $33.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of BIOSU and 1 opened new positions — a net loss of 9 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was Cubist Systematic Strategies, opening a new position worth an estimated $342K. The largest seller was Atalaya Capital Management, exiting entirely with an estimated $2.52M sold.

  • 15 institutional investors held BioPlus Acquisition Corp. Unit (BIOSU) as of Q3 2022, down from 24 in Q2 2022.
  • Funds reported $23.7M of BioPlus Acquisition Corp. Unit stock for Q3 2022, down 29% quarter-over-quarter.
  • 1 fund opened new BioPlus Acquisition Corp. Unit positions in Q3 2022 and 10 closed out, a net change of -9 holders.
  • The largest BioPlus Acquisition Corp. Unit buyer in Q3 2022 was Cubist Systematic Strategies, an estimated $342K added.
  • The largest BioPlus Acquisition Corp. Unit seller in Q3 2022 was Atalaya Capital Management, an estimated $2.52M sold.

Based on aggregated 13F filings for Q3 2022.